Farallon Capital Management LLC Quanterix Corp Transaction History

Farallon Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.26 - $23.78 $4.79 Million - $9.3 Million	-391,000 Reduced 83.01%	80,000 $1.06 Million
Q1 2024 May 15, 2024	BUY	$21.9 - $28.28 $6.29 Million - $8.12 Million	287,000 Added 155.98%	471,000 $11.1 Million
Q4 2023 Feb 14, 2024	BUY	$19.54 - $28.66 $3.6 Million - $5.27 Million	184,000 New	184,000 $5.03 Million
Q2 2022 Aug 15, 2022	SELL	$15.06 - $30.65 $4.29 Million - $8.74 Million	-285,000 Reduced 52.29%	260,000 $4.21 Million
Q2 2021 Aug 13, 2021	SELL	$43.3 - $67.17 $2.38 Million - $3.69 Million	-55,000 Reduced 9.17%	545,000 $32 Million
Q1 2021 May 17, 2021	BUY	$44.11 - $90.64 $26.5 Million - $54.4 Million	600,000 New	600,000 $35.1 Million

155

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $436M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.